This compound is a hydrochloride salt form of a cyclopropane-1,1-dicarboxamide derivative featuring a quinoline ether moiety and a fluorophenyl group. It is primarily used as an active pharmaceutical ingredient in the manufacture of pharmaceutical products.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1817759-42-4
Cabozantinib
pharmaceutical raw material
Cabozantinib S-malate
pharmaceutical raw material
Alogliptin Impurity 14
pharmaceutical raw material
Phenylbutyric acid
pharmaceutical raw material
Azd 0156
pharmaceutical raw material
Rupatadine fumarate
pharmaceutical raw material
1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;hydrochloride
LCNVAOXPKXBXEH-UHFFFAOYSA-N
COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.Cl